finasteride and Lymph Node Metastasis

finasteride has been researched along with Lymph Node Metastasis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beck, AP; Henningson, JN; Lindshield, BL; Opoku-Acheampong, AB; Unis, D	1
Coltman, CA; Darke, AK; Ford, LG; Goodman, PJ; La Rosa, FG; Lucia, MS; Parnes, HL; Thompson, IM	1
Das, K; Lim, D; Lorena, PD; Ng, LK; Reichardt, JK; Salto-Tellez, M; Shen, L; Siow, WY; Teh, M	1
Schlegel, PN	1

Trials

1 trial(s) available for finasteride and Lymph Node Metastasis

Article	Year
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention. Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:3 Topics: Aged; Antineoplastic Agents; Biopsy; Chemoprevention; Early Detection of Cancer; Finasteride; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Organ Size; Placebos; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Treatment Outcome; Tumor Burden	2008

Article

Year

Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.

Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:3

Topics: Aged; Antineoplastic Agents; Biopsy; Chemoprevention; Early Detection of Cancer; Finasteride; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Organ Size; Placebos; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Treatment Outcome; Tumor Burden

2008

Other Studies

3 other study(ies) available for finasteride and Lymph Node Metastasis

Article	Year
Preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice. PloS one, 2013, Volume: 8, Issue:10 Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Body Weight; Cholestenone 5 alpha-Reductase; Disease Progression; Dutasteride; Finasteride; Lymph Nodes; Lymphatic Metastasis; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Receptors, Tumor Necrosis Factor, Member 25	2013
Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer. Endocrine-related cancer, 2010, Volume: 17, Issue:3 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Angiogenic Proteins; Azasteroids; Biomarkers, Tumor; Blotting, Western; Bone Neoplasms; Cell Nucleus; Cell Proliferation; Dutasteride; Enzyme-Linked Immunosorbent Assay; Finasteride; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Isoenzymes; Lymphatic Metastasis; Male; Membrane Proteins; Middle Aged; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Array Analysis; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2010
Prostate cancer. Current therapy in endocrinology and metabolism, 1994, Volume: 5 Topics: 5-alpha Reductase Inhibitors; Aged; Anticarcinogenic Agents; Disease-Free Survival; Estrogens; Finasteride; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Staging; Prevalence; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Radiotherapy	1994